Succession is a biotech company that was founded to address the lack of commercial knowledge and support for biotech founders. With the aim of helping these founders scale their teams without overspending on headcount, Succession offers services such as building repeatable commercial processes and systems. As consultants, Succession helps build sustainable businesses that exceed revenue targets, empowering founders to own the process and eliminating the need to hire external support in the future.

They understand the challenges faced by biotech companies, such as the high failure rates in raising subsequent funding rounds and executive hires that fail within the first 18 months. Succession advocates for a shift from growth at all costs to efficient growth, emphasizing the importance of proven systems for growth and making the most out of existing teams. Additionally, they highlight the hidden costs of a bad sales or business development hire and provide consulting services in outbound prospecting, sales process execution, demand generation, custom enablement programs, sales skills training, and tech stack optimization.

The company is led by Harrison Waid and Nicholas Clare, both of whom have extensive experience in the biotech industry. Succession offers a free assessment to help companies identify opportunities for improvement in their positioning, messaging, and lead generation processes. With a focus on helping biotech startups thrive, Succession is dedicated to providing the support needed to navigate the challenges of commercialization and achieve long-term success